Cargando…

Prognostication in inflammatory bowel disease

Personalized care in inflammatory bowel diseases (IBD) hinges on parsing the heterogeneity of IBD patients through prognostication of their disease course and therapeutic response to allow for tailor-made treatment and monitoring strategies to optimize care. Herein we review the currently available...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spencer, Elizabeth A., Agrawal, Manasi, Jess, Tine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582521/ https://www.ncbi.nlm.nih.gov/pubmed/36275829 http://dx.doi.org/10.3389/fmed.2022.1025375

Ejemplares similares

Implications of the changing epidemiology of inflammatory bowel disease in a changing world
por: Agrawal, Manasi, et al.
Publicado: (2022)

The Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease After Bowel Resections: A Nationwide Cohort Study
por: Allin, Kristine H., et al.
Publicado: (2022)

Development of Cancer Among Patients With Pediatric-Onset Inflammatory Bowel Disease: A Meta-analysis of Population-Based Studies
por: Elmahdi, Rahma, et al.
Publicado: (2022)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes
por: Boyd, Heather A., et al.
Publicado: (2015)

Fatigue in Inflammatory Bowel Diseases: Etiologies and Management
por: Nocerino, Angelica, et al.
Publicado: (2019)

Characterizing the pre-clinical phase of inflammatory bowel disease
por: Vestergaard, Marie Vibeke, et al.
Publicado: (2023)

GLP-1 based therapies and disease course of inflammatory bowel disease
por: Villumsen, Marie, et al.
Publicado: (2021)

Intestinal Epithelium in Inflammatory Bowel Disease
por: Coskun, Mehmet
Publicado: (2014)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Risk of Cervical Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies
por: Mann, Simran, et al.
Publicado: (2022)

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease
por: Spiera, Emily, et al.
Publicado: (2022)

Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
por: Guandalini, Stefano
Publicado: (2014)

New Strategies for Treatment of Inflammatory Bowel Disease
por: Nielsen, Ole Haagen
Publicado: (2014)

Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020)

Co-pathogens in Periodontitis and Inflammatory Bowel Disease
por: Cai, Zhengwen, et al.
Publicado: (2021)

Editorial: Game Changers in Inflammatory Bowel Diseases
por: Bálint, Anita, et al.
Publicado: (2021)

Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases
por: Singh, Siddharth, et al.
Publicado: (2022)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2018)

Pathophysiological Association Between Diabetes Mellitus and Alzheimer's Disease
por: Agrawal, Manasi, et al.
Publicado: (2022)

Technological advances in inflammatory bowel disease endoscopy and histology
por: Alfarone, Ludovico, et al.
Publicado: (2022)

Inflammatory Bowel Disease: Complexity and Variability Need Integration
por: Fiocchi, Claudio
Publicado: (2018)

Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis
por: Chia, Alfred Yu Ting, et al.
Publicado: (2021)

Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood
por: Chung, Wei-Sheng, et al.
Publicado: (2021)

Treatment of Inflammatory Bowel Disease: A Comprehensive Review
por: Cai, Zhaobei, et al.
Publicado: (2021)

Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research
por: Angus, Hamish C. K., et al.
Publicado: (2020)

Validity of Inflammatory Bowel Disease Diagnoses in the Danish National Patient Registry: A Population-Based Study from the North Denmark Region
por: Albaek Jacobsen, Henrik, et al.
Publicado: (2022)

Epidemiology of Inflammatory Bowel Diseases in Nepal
por: Paudel, Mukesh S, et al.
Publicado: (2021)

Ocular Manifestations of Inflammatory Bowel Disease
por: Licona Vera, Erik, et al.
Publicado: (2023)

The Role and Function of Mucins and Its Relationship to Inflammatory Bowel Disease
por: Kang, Youra, et al.
Publicado: (2022)

Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases
por: Martins, Camilla de Almeida, et al.
Publicado: (2022)

Urinary chemerin as a potential biomarker for inflammatory bowel disease
por: Gunawan, Stefan, et al.
Publicado: (2022)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease
por: Louis, Edouard
Publicado: (2020)

Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease
por: Stürzl, Michael, et al.
Publicado: (2021)

Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease
por: Jergens, Albert E., et al.
Publicado: (2021)

Editorial: Game changers in inflammatory bowel diseases, volume II
por: Lovász, Barbara Dorottya, et al.
Publicado: (2023)

Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the Danish National Birth Cohort
por: Mendall, Michael, et al.
Publicado: (2018)

Risk of Inflammatory Bowel Disease in Patients with Chronic Myeloproliferative Neoplasms: A Danish Nationwide Cohort Study
por: Bak, Marie, et al.
Publicado: (2020)

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease
por: Parekh, Rajen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4hi0rdqa349cji93m68f2ok23j